Dasatinib: Is it All in the Dose?

Author： Condorelli Fabrizio   Genazzani Armando A.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.24, Iss.3, 2010-06, pp. : 157-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dasatinib: In Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

By Keam Susan J.  

BioDrugs, Vol. 22, Iss. 1, 2008-01 ,pp. : 59-69

Adis International

Access to resources Recommend Favorite

Activity and Safety of Dasatinib as Second-Line Treatment or in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients

By Breccia Massimo   Alimena Giuliana  

BioDrugs, Vol. 25, Iss. 3, 2011-06 ,pp. : 147-157

Adis International

Access to resources Recommend Favorite

Spotlight on Dasatinib in Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia†

By McCormack Paul L.   Keam Susan J.  

BioDrugs, Vol. 26, Iss. 1, 2012-02 ,pp. : 61-64

Adis International

Access to resources Recommend Favorite

Not all in the mind

By Baston Helen   Wray Julie  

The Practising Midwife, Vol. 15, Iss. 2, 2012-02 ,pp. : 4-4

Medical Education Solutions Limited

Access to resources Recommend Favorite

Therapies for all

By Wray Julie   Baston Helen  

The Practising Midwife, Vol. 15, Iss. 5, 2012-05 ,pp. : 4-4

Medical Education Solutions Limited

Access to resources Recommend Favorite